UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Phreesia
PHR
$773M
| $1.01M | ﹤0.01% |
40,548
-9,858
| -20% | -$217K |
|
1952
AngioDynamics
ANGO
$649M
| $1.01M | ﹤0.01% |
52,383
+6,311
| +14% | +$129K |
|
|
GDEN
1953
DELISTED
Golden Entertainment
GDEN
| $1.01M | ﹤0.01% |
25,611
+2,085
| +9% | +$98.1K |
|
1954
Great Southern Bancorp
GSBC
$878M
| $1.01M | ﹤0.01% |
17,288
+1,449
| +9% | +$84.4K |
|
1955
Orion
OEC
$409M
| $1.01M | ﹤0.01% |
65,139
+334
| +0.5% | +$5.59K |
|
|
VSTO
1956
DELISTED
Vista Outdoor Inc.
VSTO
| $1.01M | ﹤0.01% |
36,255
| – | – |
|
1957
MannKind Corp
MNKD
$1.32B
| $1.01M | ﹤0.01% |
264,665
| – | – |
|
1958
Noble Corp
NE
$6.51B
| $1M | ﹤0.01% |
39,636
| – | – |
|
1959
National Healthcare
NHC
$3.38B
| $1M | ﹤0.01% |
14,368
+763
| +6% | +$53.4K |
|
1960
Camping World
CWH
$653M
| $1M | ﹤0.01% |
46,484
+1,070
| +2% | +$28.3K |
|
1961
Aurinia Pharmaceuticals
AUPH
$2.11B
| $1M | ﹤0.01% |
99,840
+47,100
| +89% | +$527K |
|
1962
Energy Recovery
ERII
$443M
| $1M | ﹤0.01% |
51,552
+10,688
| +26% | +$207K |
|
1963
James River Group Holdings
JRVR
$217M
| $1M | ﹤0.01% |
40,380
-1,152
| -3% | -$28.2K |
|
1964
Krystal Biotech
KRYS
$9.66B
| $998K | ﹤0.01% |
15,207
| – | – |
|
1965
Innoviva
INVA
$1.48B
| $998K | ﹤0.01% |
67,640
+7,282
| +12% | +$119K |
|
1966
Shenandoah Telecom
SHEN
$746M
| $995K | ﹤0.01% |
44,809
+12
| +0% | +$271 |
|
|
LADR
1967
Ladder Capital
LADR
$1.24B
| $993K | ﹤0.01% |
94,225
+9,373
| +11% | +$106K |
|
1968
LeMaitre Vascular
LMAT
$1.86B
| $992K | ﹤0.01% |
21,778
+3,981
| +22% | +$178K |
|
|
IMGN
1969
DELISTED
Immunogen Inc
IMGN
| $989K | ﹤0.01% |
219,768
+32,642
| +17% | +$142K |
|
|
EVBG
1970
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $989K | ﹤0.01% |
35,457
-23,105
| -39% | -$936K |
|
1971
Usana Health Sciences
USNA
$286M
| $987K | ﹤0.01% |
13,643
+1,333
| +11% | +$99.3K |
|
1972
Conduent
CNDT
$264M
| $987K | ﹤0.01% |
228,509
-4,812
| -2% | -$24.2K |
|
1973
BRC Group Holdings
RILY
$289M
| $986K | ﹤0.01% |
23,340
+4,135
| +22% | +$217K |
|
|
RETA
1974
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $985K | ﹤0.01% |
32,427
+3,742
| +13% | +$112K |
|
|
AAMI
1975
Acadian Asset Management
AAMI
$3.19B
| $985K | ﹤0.01% |
54,671
-1,590
| -3% | -$32.6K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.